Erucic acid and erucic acid anilide-induced oxidative burst in human polymorphonuclear leukocytes

Free Radical Research

Volumn 27, Issue 5, 1997, Pages 477-485

  Heiskanen, Kaisa M ^a,b   Savolainen, Kai M ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Erucic acid; Erucic acid anilide; Polymorphonuclear leukocytes; Protein kinase C; Reactive oxygen species; Toxic Oil Syndrome

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ANILIDE; CALCIUM ION; ERUCIC ACID; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; REACTIVE OXYGEN METABOLITE;

ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; LEUKOCYTE ACTIVATION; NEUTROPHIL; RESPIRATORY BURST;

EID: 0031455056     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.3109/10715769709065787     Document Type: Article

References (43)

1. Aldridge, W. N. (1992). The Toxic Oil Syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism. Toxicology Letters, 64/65, 59-70.
2. Canas, R. and Kilbourne, E. K. (1987). Oil ingestion and the toxic-oil syndrome: results of a survey of residents of the Orcasur neighborhood in Madrid, Spain. International Journal of Epidemiology, 16, 3-6.
3. Diatz de Royas, F., Castro Garcia,M, Abaitua Borda, I., Alonso Gordo, J. M., Posada de la Paz, M., Kilbourne, E. M. and Tabuenca Oliver, J. M. (1987). The association of oil ingestion with toxic oil syndrome in two convents. American Journal of Epidemiology, 125, 907-911.
4. Khan, M. F., Kaphalia, B. S., Palafox, A., Jerrels, T. R. and Ansari, G. A. (1991). Toxicity of oleic acid anilide in rats. Archives of Environmental Contamination of Toxicology, 21, 571-577.
5. World Health Organization Regional Office for Europe; Copenhagen (1992). Toxic Oil Syndrome: current knowledge and future perspectives. WHO Regional Publications, European Series, No. 42. pp. 1-163.
6. Hernandez-Munoz, I., de la Torre, M. P., Pedraza, M. A., Sanchez-Alcazar, J. A., Munoz-Yague, M. T. and Solis-Herruzo, J. A. (1994). Toxic oil stimulates collagen synthesis acting at a pretranslational level in cultured fat-storing cells. Gastroenterology, 106, 691-701.
7. Kilbourne, E. M., Bernert, J. T., Posada de la Paz, M., Hill, R. H., Abaitua Borda, I., Kilbourne, B. W., Zack, M. M. and the Toxico-Epidemiologic Study Group (1988). Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. American Journal of Epidemiology, 127, 1210-1227.
8. Posada de la Paz, M., Philen, R. M., Abaitua Borda, I., Diez Ruiz-Navarro, M., Abraira Santos, V., Pozo Rodriguez, F., Pla Mestre, R., Pollan Santamaria, M., Sicilia Socias, J. M. and Azpeitia Gamazo, P. (1994). Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Epidemiology, 5, 404-409.
9. Bell, S. A., Hobbs, M. V. and Rubin, R. L. (1992). Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. Journal of Immunology, 148, 3369-3376.
10. Bell, S. A., Du Clos, T. W., Khursigaram, G., Picazo, J. J. and Rubin, R. L. (1995). Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the Toxic Oil Syndrome. Journal of Autoimmunity, 8, 293-303.
11. Tabuenca, J. M.(1981). Toxic allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet, 2, 567-568.
12. Yoshida, S. H., German, J. B., Fletcher, P. and Gershwin, M. E. (1994). The toxic oil syndrome: a perspective on immunotoxicological mechanisms. Regulatory Toxicology and Pharmacology, 19, 60-79.
13. Heiskanen, K. M., Naarala, J. and Savolainen, K. M. (1995). The effects of N-(5-vinyl-1,3-thiazolidin-2-ylidene)phenylamine (5-VTPA) on the changes in free intracellular calcium and the production of reactive oxygen metabolites in human leukocytes. Toxicology, 100, 195-200.
14. Heiskanen, K., Ruotsalainen, M. and Savolainen, K. (1995). Interactions of cis-fatty acids and their anilides with formyl-methionyl-leucyl-phenylalanine, phorbol myristate acetate and dioctanoyl-s,n-glycerol in human leukocytes. Toxicology, 104, 115-121.
15. Heiskanen, K. M. and Savolainen, K. M. (1996). Formyl-Methionyl-Leucyl-Phenylalanine and a calcium ionophore A23187 reverse the inhibition of phorbol myristate acetate-induced oxidative burst by linoleic and oleic acid anilide. Toxicology, 110, 39-45.
16. Heiskanen, K. M. and Savolainen, K. M. (1996). Palmitic acid anilide-induced respiratory burst in human polymorphonuclear leukocytes is inhibited by a protein kinase C inhibitor, RO 31-8220. Free Radical Biology and Medicine, in press.
17. Fantone, J. C. and Ward, P. A. (1985). Polymorphonuclear leukocyte-mediated cell and tissue injury:oxygen metabolites and their relations to human disease. Human Pathology, 16, 973-978.
18. Smith, R. J., Justen, J. M., Nidy, E. G., Sam, L. M. and Bleasdale, J. E. (1993). Transmembrane signaling in human polymorphonuclear neutrophils: 15(S)-hydroxy-(5Z, 8Z, 11Z, 13E)-eicosatetraenoic acid modulates receptor agonist triggered activation. Proceedings of National Academy of Sciences of the United States of America, 90, 7270-7274.
19. Reyes, H., Ribalta, J., Hernandez, I., Arrese, M., Pak, N., Wells, M. and Kirsch, R. E. (1995). Is dietary eruric acid hepatotoxic in pregnancy? An experimental study in rats and hamsters. Hepatology, 21, 1373-1379.
20. Kraemer, J. K. G., Sauer, F. D., Wolynetz, M. S., Famworth, E. R. and Johnston, K. M. (1992). Effects of dietary saturated fat on erucic acid induced myocardial lipidosis in rats. Lipids, 27, 619-623.
21. Sargent, J. R., Coupland, K. and Wilson, R. (1993). Nervonic acid and demyelinating disease. Medical Hypotheses, 42, 237-242.
22. Asano, J., Suzuki, Y., Yajima, S., Inoue, K., Shimozawa, N., Kondo, N., Murase, M. and Orii, T. (1994). Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy. Brain and Development, 16, 454-458.
23. Rizzo, W. B., Leshner, R. T., Odone, A., et al. (1989). Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology, 39, 1415-1422.
24. Thelen, M., Dewald, B. and Baggiolini, M. (1993). Neutrophil signal transduction and activation of the respiratory burst. Physiological Reviews, 73, 797-821.
25. Nishizuka, Y. (1984). The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature, 308, 693-698.
26. Böyum, A. (1968). Isolation of mononuclear cells and granulocytes from human blood. Scand. Journal of Clinical and Laboratory Investigation, 21, 77-89.
27. Weening, R. S., Roos, D. and Loos, J. A. (1974). Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations. Journal of Laboratory and Clinical Medicine, 83, 570-576.
28. 2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry, 260, 3440-3450.
29. Dechatelet, L. R., Long, G. D., Shirley, P. S., Bass, D. A., Thomas, M. J., Henderson, F. W. and Cohen, M. S. (1982). Mechanism of the luminol-dependent chemiluminescence of human neutrophils. Journal of Immunology, 129, 1589-1593.
30. Twomey, B., Muid, R. E., Nixon, J. S., Sedgwick, A. D., Wilkinson, S. E. and Dale, M. M. (1990). The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burst. Biochemical and Biophysical Research Communications, 171, 1087-1092.
31. Naarala, J. T., Loikkanen, J. J., Ruotsalainen, M. and Savolainen, K. M. (1995). Lead amplifies glutamate-induced oxidative stress. Free Radical Biology and Medicine, 19, 689-693.
32. James, T. N., Gomez-Sanchez, M. A., Martinez-Tello, F. J., Posada de la Paz, M., Abaitua-Borda, I. and Soldevilla, L. B. (1991). Cardiac abnormalities in the Toxic Oil Syndrome, with comparative observations on the Eosinophilia-Myalgia Syndrome. Journal of American College of Cardio-logy, 18, 1367-1379.
33. Garcia Gil, M., van Lookeren Campagne, M. W., Alemany, S., Municio, A. M. and Mato, J. M. (1983). Effect of fatty acid anilides on the generation of arachidonic acid by human polymorphonuclear leukocytes. FEBS Letters, 162, 151-155.
34. Garcia Gil, M., Traver, J., Suarez, J., Cao, D. M. and Mato, J. M. (1984). Evidence for generation of leukotriene B4 in human polymorphonuclear leukocytes treated with linoleylanilide. Biochemical Pharmacology, 33, 3303-3306.
35. Bloque, G., Vargas, D., Bulbena, O., Rosello-Catafau, J. and Gelpi, E. (1993). Cyclooxygenase and lipoxygenase arachidonate metabolites synthesized by mouse peritoneal macrophages: in vitro effect of N-phenyllinoleamide from toxic oil samples. Agents and Actions, 38, 38-43.
36. Berridge, M. J. and Irvine, R. F. (1985). Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature, 312, 315-321.
37. Asaoka, Y., Nakamura, S., Nakamura, S., Yoshida, S. K. and Nishizuka, Y. (1992). Protein kinase C, calcium and phospholipid degradation. Trends in Biochemical Sciences, 14, 414-417.
38. phox during activation. Journal of Biological Chemistry, 269, 23431-23436.
39. de Jonge, H. W., Dekkers, D. H. and Lamers, J. M. (1996). Polyunsaturated fatty acids and signalling via phospholipase C-beta and A2 in myocardium. Molecular and Cellular Biochemistry, 157, 199-210.
40. Heiskanen, K. M. and Savolainen, K. M. (1996). Effects of 3-pheylamino-1,2-propanediol and its mono-and di-oleylesters on the production of reactive oxygen meta-bolites in human polymorphonuclear leukocytes. Toxicology Letters, in press.
41. Phelps, R. G. and Fleischmajer, R. (1988). Clinical, pathologic, and immunopathologic manifestations of the toxic oil syndrome. Analysis of fourteen cases. Journal of the Academy of Dermatology, 18, 313-324.
42. Sellmayer, A., Danesch, U. and Weber, P. C. (1996). Effects of different polyunsaturated fatty acids on growth-related early gene expression and cell growth. Lipids, 31, Supplement, S37-40.
43. Danesch, U., Weber, P. C. and Sellmayer, A. (1996). Differential effects of n-6 and n-3 polyunsaturated fatty acids on cell growth and early gene expression in Swiss 3T3 fibroblasts. Journal of Cell Physiology, 168, 618-624.